We recently established a tumor organoid system by co-culturing Kras activated AT2 cells with lung mesenchymal cells (Dost et al, 2020), making it possible to characterize the molecular changes that occur in the transition of normal epithelial cells to tumorigenic cells. The gene discussed is KRAS; the disease is neoplasm.